Skip to main content

Press Releases

July 27, 2018

WASHINGTON, D.C. – Congressman John Sarbanes (D-Md.) today joined Rep. Elijah E.

Issues:Health Care
July 26, 2018
WASHINGTON, D.C. – Congressmen John Sarbanes (D-Md.) and Gerry Connolly (D-Va.) today introduced the Telework Metrics and Cost Savings Act, a bill to prohibit the kind of indiscriminate anti-telework policies the Trump Administration has announced for the Department of Education and U.S. Department of Agriculture.
July 25, 2018

WASHINGTON, D.C. – Democracy Reform Task Force Chair Rep. John Sarbanes (D-Md.) released the following statement today after U.S. District Judge Peter Messitte rejected President Trump's attempt to halt a lawsuit accusing him of violating the U.S. Constitution by maintaining a personal financial interest in the Trump International Hotel in Washington:

July 25, 2018

WASHINGTON, D.C. – Democracy Reform Task Force Chair Rep. John Sarbanes (D-Md.) joined Senator Michael Bennet (D-Colo.) today in introducing the Curtailing Lobbyists and Empowering Americans for a New (CLEAN) Politics Act of 2018, a bill to curb pay-to-play politics and limit the undue access and influence of lobbyists in Washington.

July 24, 2018
WASHINGTON, D.C. – The Maryland Congressional delegation today called on the U.S. Environmental Protection Agency (EPA) to reconsider its denial of Maryland’s petition requesting that action be taken to provide relief against out-of-state air pollution. In particular, the delegation’s letter to EPA Acting Administrator Andrew Wheeler noted 36 electric generating units located upwind of Maryland’s border that – due to prevailing wind patterns – are disproportionately impacting Maryland’s air quality and public health.
Issues:Environment
July 23, 2018
WASHINGTON, D.C. – Congressman John Sarbanes (D-Md.) today introduced the Biosimilars Competition Act of 2018, a bipartisan bill that would require biologic and biosimilar drug manufacturers to report anticompetitive agreements that keep lower-cost drugs off the market. These so-called “pay-for-delay” agreements – often made in secret – provide millions of dollars to big pharmaceutical companies while forcing everyday Americans to pay more for prescription drugs.
Issues:Health Care
July 19, 2018
WASHINGTON, D.C. – Congressman John Sarbanes (D-Md.) today joined the entire Maryland Congressional Delegation in urging Homeland Security Secretary Kirstjen Nielsen to approve Maryland’s request for technical assistance to review and protect the state’s election systems.
July 19, 2018

WASHINGTON, D.C. – Democracy Reform Task Force Chair Rep. John Sarbanes (D-Md.) today joined Representatives Steny Hoyer (D-Md.), Elijah E. Cummings (D-Md.), John Delaney (D-Md.), C.A. Dutch Ruppersberger (D-Md.), Anthony Brown (D-Md.), Jamie Raskin (D-Md.), Robert A.

July 19, 2018

WASHINGTON, D.C. – Democracy Reform Task Force Chair Rep. John Sarbanes (D-Md.) today joined House Judiciary Committee Ranking Member Jerrold Nadler (D-N.Y.), House Oversight and Government Reform Committee Ranking Member Elijah E. Cummings (D-Md.) and House Administration Committee Ranking Member Robert A.

July 16, 2018
WASHINGTON, D.C. – Democracy Reform Task Force Chair Rep. John Sarbanes (D-Md.) released the following statement today after President Donald Trump’s meeting with Russian President Vladimir Putin.